Palantir Technologies Inc.'s 30% dip signals a buying opportunity amid growth in AI investments and defense spending. Click ...

NHS chief data and analytics officers are worried about the way NHS England is running its Federated Data Platform programme.

In healthcare we trust—or do we? A breakdown in trust, like the schism in the transatlantic alliance, should make us think again about whether the current model requires reinvention. An anonymous ...

Palantir (NASDAQ: PLTR) has been one of the stock market's biggest success stories over the last two years. Shares of the AI software company, which is best known for its work with government defense ...

The data analysis and surveillance company is the darling of Wall Street for its use of artificial intelligence in defense ...

Palantir's growth has been soaring in the U.S., but the defense tech company's growth in Europe is plateauing. Its overseas struggles could exacerbate other risks for the stock. Shares of the AI ...

Palantir does have a number of major clients in Europe, including the U.K.'s National Health Service (NHS), but the company's sluggish performance in Europe may reflect the reputational risk of ...

The Palantir share price has bombed over the past week or so, leaving this writer wondering if now's the time to snap up this ...

NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framework, reigniting debate ...